RecruitingNot applicableNCT05763251

Comparison of Uncomplicated Candidemia Therapy Duration in Children

Studying Invasive candidiasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Arkansas Children's Hospital Research Institute
Principal Investigator
Brian Fisher, DO
Children's Hospital of Philadelphia
Intervention
therapy duration(other)
Enrollment
420 target
Eligibility
18 years · All sexes
Timeline
2023 – 2032

Study locations (17)

Collaborators

Westat · St. Jude Children's Research Hospital · George Washington University · Children's Hospital of Philadelphia · National Institute of Allergy and Infectious Diseases (NIAID)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05763251 on ClinicalTrials.gov

Other trials for Invasive candidiasis

Additional recruiting or active studies for the same condition.

See all trials for Invasive candidiasis →

← Back to all trials